- Home
- FOXX vs KZR Comparison
FOXX vs KZR Comparison
Compare FOXX & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXX
- KZR
- Stock Information
- Founded
- FOXX 2017
- KZR 2015
- Country
- FOXX United States
- KZR United States
- Employees
- FOXX N/A
- KZR N/A
- Industry
- FOXX
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- FOXX
- KZR Health Care
- Exchange
- FOXX Nasdaq
- KZR Nasdaq
- Market Cap
- FOXX 30.5M
- KZR 29.7M
- IPO Year
- FOXX N/A
- KZR 2018
- Fundamental
- Price
- FOXX $4.00
- KZR $6.21
- Analyst Decision
- FOXX
- KZR Hold
- Analyst Count
- FOXX 0
- KZR 4
- Target Price
- FOXX N/A
- KZR $6.00
- AVG Volume (30 Days)
- FOXX 24.5K
- KZR 468.5K
- Earning Date
- FOXX 11-18-2025
- KZR 11-07-2025
- Dividend Yield
- FOXX N/A
- KZR N/A
- EPS Growth
- FOXX N/A
- KZR N/A
- EPS
- FOXX N/A
- KZR N/A
- Revenue
- FOXX $65,919,166.00
- KZR N/A
- Revenue This Year
- FOXX N/A
- KZR N/A
- Revenue Next Year
- FOXX N/A
- KZR N/A
- P/E Ratio
- FOXX N/A
- KZR N/A
- Revenue Growth
- FOXX 1941.75
- KZR N/A
- 52 Week Low
- FOXX $2.45
- KZR $3.53
- 52 Week High
- FOXX $11.00
- KZR $8.17
- Technical
- Relative Strength Index (RSI)
- FOXX 37.13
- KZR 75.38
- Support Level
- FOXX $4.09
- KZR $6.06
- Resistance Level
- FOXX $4.78
- KZR $6.30
- Average True Range (ATR)
- FOXX 0.26
- KZR 0.24
- MACD
- FOXX 0.04
- KZR 0.06
- Stochastic Oscillator
- FOXX 0.00
- KZR 91.74
About FOXX Foxx Development Holdings Inc. Common Stock
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.